Hosted on MSN3d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD
By Dr. Chinta Sidharthan The researchers evaluated budesonide-glycopyrrolate-formoterol and ...
Study compares single-inhaler triple therapies for treatment of COPD
For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve ...
Eosinophilic Esophagitis Market Insight, Epidemiology And Market Forecast To 2034
The total market size of eosinophilic esophagitis in 2023 was approximately USD 1.80 trillion in the 7MM, which is expected to grow during the forecast period (2020-2034). Among EU4 and the UK, ...
ons.gov.uk28d
GDP monthly estimate, UK: October 2024
More detailed breakdowns on production are available in our Index of Production, UK: October 2024 bulletin. Monthly construction output is estimated to have fallen by 0.4% in October 2024, following ...